Form DRS - Draft Registration Statement:
SEC Accession No. 0001683168-19-000810
Filing Date
2019-03-28
Accepted
2019-03-27 19:16:57
Documents
4

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 891005
2 filename2.htm EX-23.1 3443
3 GRAPHIC image_001.jpg GRAPHIC 23892
4 GRAPHIC image_002.jpg GRAPHIC 42409
  Complete submission text file 0001683168-19-000810.txt   987071
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-02562 | Film No.: 19709553
SIC: 2834 Pharmaceutical Preparations